3 citations
,
June 2019 in “Veterinary record case reports” This case report describes a miniature dachshund with pustular dermatitis and other symptoms, developing pemphigus foliaceus after receiving afoxolaner, which was effectively managed with prednisone and cyclosporine.
1 citations
,
September 2024 in “Veterinary Medicine and Science” In this study, researchers found that a single oral dose of afoxolaner was safe and effective in treating a severe case of Trixacarus caviae mange in a guinea pig, achieving full remission of clinical signs and mite eradication within 4 weeks without needing repeated treatment.
July 2025 in “Veterinary Parasitology Regional Studies and Reports” This study found that both oral afoxolaner (NexGard®) and topical Frontline Combo® achieved 100% efficacy in eradicating Heterodoxus spiniger infestations within 30 days in dogs, with significant reductions in associated symptoms like hair loss and pruritus.
January 2025 in “International Journal of Advanced Biochemistry Research” This case report described a one-year-old male husky dog with severe itching and skin lesions caused by Demodex canis, where treatment with Nexgard® and other supportive therapies over two weeks improved the dog's condition, indicating Nexgard® as a viable option for managing canine demodicosis.
January 2024 in “International Journal of Advanced Biochemistry Research” In this case report, a one-year-old male husky with canine demodicosis exhibited significant improvement in skin condition after receiving treatment with Nexgard®, antibiotics, and supportive therapies, suggesting Nexgard® as an effective option for managing this condition.